PT-141 (Bremelanotide) is a synthetic peptide analog commonly studied for its effects on melanocortin receptors and central nervous system signaling. Unlike compounds that act through vascular pathways, PT-141 is researched for its direct interaction with neurological pathways involved in behavioral and physiological responses.

In laboratory settings, PT-141 is often explored for its potential to:

• Support melanocortin receptor pathway research
• Influence central nervous system signaling
• Assist in studies involving behavioral response mechanisms
• Contribute to research on neurological and hormonal interactions

PT-141 is widely utilized in research models focused on understanding how melanocortin activation impacts central signaling and systemic responses.

Key Features:

• Synthetic melanocortin receptor agonist
• Targets central nervous system pathways
• High-purity lyophilized powder
• Consistent and reliable for laboratory applications